Microbot Medical shareholders approve increase in authorized common shares to 120M; Series I options become exercisable

Microbot Medical Inc.

Authorized common shares increased from 61M to 120M; total authorized shares now 121M (including 1M preferred).
Stockholders approved issuance of Series I options (12,206,578 shares at $2.13) and placement agent options (305,164 shares at $2.6625); now immediately exercisable.
Amendment to 2020 Omnibus Performance Award Plan approved, adding 2,591,019 authorized shares.
Class I directors elected: Harel Gadot, Martin Madden, Tal Wenderow; each received >3M votes for.
Brightman Almagor Zohar & Co. ratified as independent auditor for FY2025 with 13.2M votes in favor.

item 3.03item 5.03item 5.07item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.